These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22653536)

  • 1. Prenatal healthcare providers' Gaucher disease carrier screening practices.
    Falcone D; Wood EM; Mennuti M; Xie SX; Van Deerlin VM
    Genet Med; 2012 Oct; 14(10):844-51. PubMed ID: 22653536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier screening for Gaucher disease in couples of mixed ethnicity.
    Wallerstein R; Starkman A; Jansen V
    Genet Test; 2001; 5(1):61-4. PubMed ID: 11336404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal panel screening considerations for non-neuronopathic Gaucher disease in the Ashkenazi-Jewish population.
    Kannai R; Chertok IR
    Isr Med Assoc J; 2006 May; 8(5):347-50. PubMed ID: 16805236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
    Zuckerman S; Lahad A; Shmueli A; Zimran A; Peleg L; Orr-Urtreger A; Levy-Lahad E; Sagi M
    JAMA; 2007 Sep; 298(11):1281-90. PubMed ID: 17878420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional survey of genetic counselors providing carrier screening regarding GBA variants and Parkinson disease susceptibility.
    Jones TA; Schulze J; Aufox S; Rothstein J; Arjunan A
    J Assist Reprod Genet; 2022 Mar; 39(3):747-755. PubMed ID: 35146589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.
    Beutler E; Gelbart T; Kuhl W; Sorge J; West C
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10544-7. PubMed ID: 1961718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher disease mutations in non-Jewish patients.
    Beutler E; Gelbart T
    Br J Haematol; 1993 Oct; 85(2):401-5. PubMed ID: 8280613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes.
    Balwani M; Fuerstman L; Kornreich R; Edelmann L; Desnick RJ
    Arch Intern Med; 2010 Sep; 170(16):1463-9. PubMed ID: 20837833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.
    Scott SA; Edelmann L; Liu L; Luo M; Desnick RJ; Kornreich R
    Hum Mutat; 2010 Nov; 31(11):1240-50. PubMed ID: 20672374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sixteen years of prenatal consultations for the N370S/N370S Gaucher disease genotype: what have we learned?
    Eitan Y; Abrahamov A; Phillips M; Elstein D; Zimran A
    Prenat Diagn; 2010 Oct; 30(10):924-7. PubMed ID: 20721872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Look before you leap. Carrier screening for type 1 Gaucher disease: difficult questions.
    Borry P; Clarke A; Dierickx K
    Eur J Hum Genet; 2008 Feb; 16(2):139-40. PubMed ID: 18043719
    [No Abstract]   [Full Text] [Related]  

  • 16. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.
    Zimran A; Gelbart T; Westwood B; Grabowski GA; Beutler E
    Am J Hum Genet; 1991 Oct; 49(4):855-9. PubMed ID: 1897529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
    Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
    Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular characterization of Gaucher disease in South Africa.
    Morar B; Lane AB
    Clin Genet; 1996 Aug; 50(2):78-84. PubMed ID: 8937765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new diagnostic test for Gaucher disease suitable for population screening.
    Sakallah SA; Sansieri C; Kopp DW; Cooper DL; Barranger JA
    PCR Methods Appl; 1994 Aug; 4(1):1-5. PubMed ID: 9018309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients.
    Horowitz M; Tzuri G; Eyal N; Berebi A; Kolodny EH; Brady RO; Barton NW; Abrahamov A; Zimran A
    Am J Hum Genet; 1993 Oct; 53(4):921-30. PubMed ID: 8213821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.